Literature DB >> 20638629

Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea.

Jeremy Herman1, Venkata Pokkunuri, Lena Braham, Mark Pimentel.   

Abstract

BACKGROUND: A significant gender disparity has been observed in individuals with irritable bowel syndrome (IBS), with females outnumbering males, especially in constipation-predominant IBS (C-IBS). However, this observation is based on Rome criteria categorization and does not take into account the severity of constipation or diarrhea.
OBJECTIVE: In a large prospective data set, gender differences across the severity of constipation and diarrhea were examined in patients with IBS.
METHODS: Consecutive adult patients with Rome I positive IBS who were referred to a tertiary care medical center (Cedars-Sinai Medical Center, Los Angeles, California) in 1999-2003 were given a questionnaire. The questionnaire asked subjects to rate their constipation and diarrhea according to perceived severity using a scale from 0 (none) to 5 (very severe). C-IBS was determined to be present if the severity of constipation was greater than the severity of diarrhea (sevC > sevD). If sevD > sevC, subjects were considered to have diarrhea-predominant IBS (D-IBS). To further categorize their symptoms, subjects were then grouped by the difference between the severity of constipation and diarrhea, creating a range of values from -5 to +5. For each of these 11 constipation/diarrhea severity values, the female:male ratio was determined. The severity of constipation to diarrhea was compared by Spearman rank correlation.
RESULTS: A total of 429 subjects with IBS (325 women: mean [SD] age, 42.5 [0.8] years; 104 men: mean age, 42.2 [1.7] years) completed the questionnaire. Constipation occurred more frequently in women (79.7%) compared with men (61.5%) (odds ratio [OR] = 2.49; 95% CI, 1.55-4.02). The prevalence of diarrhea was similar between the sexes. Whereas C-IBS was more common in women (31.8%) than in men (26.0%) (OR = 2.03; 95% CI, 1.24-3.30), D-IBS was more prevalent in men (62.5%) than in women (36.3%) (OR = 2.39; 95% CI, 1.53-3.75). When the female:male ratio was evaluated across the 11 severity score categories of constipation and diarrhea, the greater the sevC - sevD score, the higher the proportion of women (R = 0.80; P = 0.003).
CONCLUSION: In this study of patients with IBS, the observation of the association of constipation and gender in IBS is extended to indicate that the female:male ratio significantly increases according to the severity of constipation relative to the severity of diarrhea. Copyright (c) 2010 Excerpta Medica Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20638629     DOI: 10.1016/j.genm.2010.06.007

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  13 in total

1.  Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Stephen J Vanner; William G Paterson; Ron J Bridges
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

2.  Association of genetic polymorphisms in HTR3A and HTR3E with diarrhea predominant irritable bowel syndrome.

Authors:  Qiao-Yan Gu; Jun Zhang; Yi-Chao Feng; Guang-Rong Dai; Wei-Ping Du
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.

Authors:  Jessica L Buono; Stavros Tourkodimitris; Phil Sarocco; Jeffrey M Johnston; Robyn T Carson
Journal:  Am Health Drug Benefits       Date:  2014-08

4.  Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients.

Authors:  Sanam Javid Anbardan; Nasser Ebrahimi Daryani; Seyed-Mohammad Fereshtehnejad; Sahar Taba Taba Vakili; Mohammad Reza Keramati; Hossein Ajdarkosh
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

Review 5.  Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.

Authors:  Mathieu Meleine; Julien Matricon
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

6.  Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study.

Authors:  Linda Bjork Olafsdottir; Hallgrimur Gudjonsson; Heidur Hrund Jonsdottir; Einar Björnsson; Bjarni Thjodleifsson
Journal:  Gastroenterol Res Pract       Date:  2012-03-14       Impact factor: 2.260

7.  Word-of-Mouth Innovation: Hypothesis Generation for Supplement Repurposing based on Consumer Reviews.

Authors:  Jung-Wei Fan; Yves A Lussier
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 8.  Mechanisms of Stress-induced Visceral Pain.

Authors:  Beverley Greenwood-Van Meerveld; Anthony C Johnson
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

Review 9.  Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

Review 10.  Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.

Authors:  Mahmoud Soubra; Ron Schey
Journal:  Clin Med Insights Gastroenterol       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.